𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Breast carcinoma at the extremes of age: A comparison of patients younger than 35 years and older than 75 years

✍ Scribed by Paul Peter Rosen; Martin L. Lesser; David W. Kinne

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
552 KB
Volume
28
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

We assessed the prognosis of patients with breast carcinoma at the extremes of the age distribution of the disease. The groups examined were 166 women 35 years or less and 169 at least 75 years old. Analysis of recurrence and survival showed no significant difference between the groups as a whole or when they were stratified by nodal status. Life expectancy of elderly women with breast carcinoma was significantly reduced when compared with a β€œnormal” age‐matched population. Medullary carcinoma was more frequent in young women while a relatively higher proportion of colloid and invasive lobular carcinoma occurred in elderly women. Bilateral carcinoma was found with nearly equal frequency in both age groups. However, elderly women were more likely to have been treated previously for contralateral carcinoma while young women tended to develop asynchronous, subsequent carcinoma.

πŸ“œ SIMILAR VOLUMES

The impact of mammography in 1096 consec
The impact of mammography in 1096 consecutive patients with breast cancer, 1979-1993. Equal value for patients younger and older than age 50 years
✍ Hiram S. Cody III πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 472 KB πŸ‘ 1 views

Background. Although the benefit of screening mammography in healthy women younger than age 50 remains controversial, few studies have addressed the impact of mammography over time and by patient age, on means of diagnosis and stage of disease among women with breast cancer. Methods. One thousand n

Rare ductal adenocarcinoma of the pancre
Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years : An analysis of its features and a literature review
✍ Jutta LΓΌttges; Claudia Stigge; Maike Pacena; GΓΌnter KlΓΆppel πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Pancreatic ductal adenocarcinomas (PDACs) are extremely rare before age 40 years. The objective of the current study was to determine whether the features of PDACs in patients age < 40 years differ from those in older patients. The authors reviewed the literature and thei

A VM 26-based regimen for patients with
A VM 26-based regimen for patients with previously untreated non-Hodgkin lymphoma. Prolonged disease-free survival in patients younger than 60 years of age: A phase II trial of the eastern cooperative oncology group
✍ Leo I. Gordon; Janet Andersen; Stephanie Gregory; Joseph Mazza; Paul Chervenick; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 545 KB

Background. The epidophyllotoxin VM 26 has been shown to have single-agent activity in patients with diffuse aggressive lymphoma. In an attempt to determine its activity in combination with other agents known to be effective in lymphoma, a Phase I1 trial of a novel chemotherapy regimen was conducted

Significance of age in acute myeloid leu
Significance of age in acute myeloid leukemia patients younger than 30 years : A common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A
✍ Ursula Creutzig; Thomas BΓΌchner; Maria C. Sauerland; Martin Zimmermann; Dirk Rei πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 343 KB

## Abstract ## BACKGROUND. Data on the impact of age in acute myeloid leukemia (AML) patients <30 years treated in pediatric and adult trials are scarce. ## METHODS. In all, 891 patients <18 years were treated in the pediatric trials AML‐BFM 93/98 and 290 adolescents and young adults (>16 to <30